Irritant susceptibility and weal and flare reactions to bioactive agents in atopic dermatitis. I. Influence of disease severity.
The two main pathogenetic characteristics of atopic dermatitis (AD) are: (i) antigen-dependent 'specific' reactivity, and (ii) altered non-immunological 'non-specific' reactivity. Our understanding of the role of non-specific reactivity is hampered by the fact that methods available for its quantification are limited. The aim of the present study was to assess the usefulness of two parameters as quantitative measures of non-specific skin reactivity in AD: (i) susceptibility to repeated epicutaneous exposure to an irritant (sodium lauryl sulphate, SLS), assessed by visual scoring and transepidermal water loss (TEWL) measurement, and (ii) reactivity to intracutaneously injected bioactive agents (codeine, FMLP, histamine, methacholine, substance P, trypsin), assessed by measurement of weal and flare size. These two parameters were tested in a group of AD patients, subdivided according to the severity of their dermatitis, and a control group. The visual score and TEWL after SLS exposure tended to be higher in the AD group than in the control group. Furthermore, visual score and post-exposure TEWL were positively correlated with the dermatitis severity score. Weal size following injection of codeine, histamine and substance P, and flare size following injection of all agents, except methacholine, were significantly lower in the AD group than in the control group. Negative correlations were found between weal and flare sizes and the dermatitis severity score. These findings can be explained by down-regulation of structures involved in weal and flare reactions. In conclusion, we propose that epicutaneous irritant susceptibility and reactivity to intracutaneous bioactive agents may be useful indicators of non-specific skin reactivity in AD.
Department of Dermatology, University Hospital, Groningen, The Netherlands.
R A
RA
Tupker
P J
PJ
Coenraads
V
V
Fidler
M C
MC
De Jong
J B
JB
Van der Meer
J G
JG
De Monchy
D000293:Adolescent; D000328:Adult; D003876:Dermatitis, Atopic / Q000503:physiopathology*; D004342:Drug Hypersensitivity; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced*; D007509:Irritants; D008875:Middle Aged; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects; D014581:Urticaria / Q000139:chemically induced
D007509:Irritants